Prevalence of enterohaemorrhagic Escherichia coli O157:H7 in drinking water and its predicted impact on diarrhoeic HIV/AIDS patients in the Amathole District, Eastern Cape Province, South Africa

Immunosuppressed persons such as HIV/AIDS patients are at risk of acquiring diarrhoeal infections from water-borne E. coli O157:H7. In the present study, we investigated the prevalence of E. coli O157:H7 in drinking water collected from selected distribution systems within the Amathole District of the Eastern Cape and its predicted impact on diarrhoeic conditions of HIV/AIDS persons living in this area. One hundred and eighty water samples and 360 stool swabs from confirmed and nonconfirmed HIV/AIDS diarrhoeic patients were analysed. Escherichia coli O157:H7 were isolated using enrichment culture and confirmed using molecular techniques. Of the 180 drinking water samples, 46 (25.56%) were positive for E. coli O157. The prevalence of E. coli O157 in the stools was at 36.39% (131/360) of which 56.5% (74/131) and 43.5% (57/131) were from stools of confirmed and non-confirmed HIV/AIDS patients, respectively. Molecular analysis of 27, 25 and 29 representative presumptive E. coli O157 from water and stools of confirmed and non-confirmed HIV/AIDS patients, respectively, revealed that 14.81%, 36% and 17.24% of the isolates were E. coli O157:H7. The findings predicted a possible link between E. coli O157:H7 isolated from drinking water and diarrhoeic conditions of both confirmed and non-confirmed HIV/AIDS patients visiting Frere Hospital for treatment.